Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Lippi, G. Targher, G. Cervellin (2015)
Troponin in Stable Ischemic Heart Disease and Diabetes.The New England journal of medicine, 373 20
V. Ferreira, J. Schulz-Menger, G. Holmvang, C. Kramer, I. Carbone, U. Sechtem, I. Kindermann, M. Gutberlet, L. Cooper, Peter Liu, M. Friedrich (2018)
Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations.Journal of the American College of Cardiology, 72 24
O. Spruijt, L. Vissers, H. Bogaard, M. Hofman, A. Vonk-Noordegraaf, J. Marcus (2015)
Increased native T1-values at the interventricular insertion regions in precapillary pulmonary hypertensionThe International Journal of Cardiovascular Imaging, 32
J. Stack, P. Mclaughlin, C. Sinnot, M. Henry, P. MacEneaney, A. Eltahir, S. Harney (2010)
Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisoloneScandinavian Journal of Rheumatology, 39
G. Luca, G. Cavalli, C. Campochiaro, M. Tresoldi, L. Dagna (2018)
Myocarditis: An Interleukin-1-Mediated Disease?Frontiers in Immunology, 9
G. Luca, C. Campochiaro, S. Sartorelli, G. Peretto, S. Sala, A. Palmisano, A. Esposito, C. Candela, C. Basso, S. Rizzo, G. Thiene, P. Bella, L. Dagna (2020)
Efficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: A prospective cohort study.Journal of autoimmunity
G. Luca, S. Bosello, G. Canestrari, G. Cavalli, L. Dagna, G. Ferraccioli (2017)
QTc interval prolongation in Systemic Sclerosis: Correlations with clinical variables and arrhythmic risk.International journal of cardiology, 239
G. Peretto, S. Sala, G. Luca, C. Campochiaro, S. Sartorelli, A. Cappelletti, S. Rizzo, A. Palmisano, A. Esposito, A. Margonato, M. Tresoldi, G. Thiene, C. Basso, L. Dagna, P. Bella (2019)
Impact of systemic immune-mediated diseases on clinical features and prognosis of patients with biopsy-proved myocarditis.International journal of cardiology, 280
A. Hachulla, David Launay, V. Gaxotte, P. Groote, N. Lamblin, Patrick Devos, P. Hatron, J. Beregi, E. Hachulla (2008)
Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patientsAnnals of the Rheumatic Diseases, 68
A. Pingitore, S. Guiducci, M. Conforti, D. Marchi, L. Gargani, A. Moggi-Pignone, S. Randone, M. Lombardi, E. Picano, M. Matucci-Cerinic (2013)
Early detection of myocardial and pulmonary oedema with MRI in an asymptomatic systemic sclerosis patient: successful recovery with pulse steroid.Rheumatology, 52 10
F. Thuny, D. Lovrić, F. Schnell, C. Bergerot, L. Ernande, V. Cottin, G. Derumeaux, P. Croisille (2014)
Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis.Radiology, 271 2
H. Kobayashi, I. Yokoe, Masaharu Hirano, Tetsuya Nakamura, Y. Nakajima, K. Fontaine, J. Giles, Yasuyuki Kobayashi (2008)
Cardiac Magnetic Resonance Imaging with Pharmacological Stress Perfusion and Delayed Enhancement in Asymptomatic Patients with Systemic SclerosisThe Journal of Rheumatology, 36
E. Cesare, S. Battisti, A. Sibio, P. Cipriani, R. Giacomelli, V. Liakouli, P. Ruscitti, C. Masciocchi (2013)
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI).European journal of radiology, 82 6
G. Valentini, D. Huscher, A. Riccardi, S. Fasano, R. Irace, V. Messiniti, M. Matucci-Cerinic, S. Guiducci, O. Distler, B. Maurer, J. Avouac, I. Tarner, M. Frerix, G. Riemekasten, E. Siegert, L. Czirják, V. Lóránd, C. Denton, S. Nihtyanova, U. Walker, V. Jaeger, F. Galdo, G. Abignano, L. Ananieva, A. Gherghe, C. Mihai, J. Henes, T. Schmeiser, A. Vacca, S. Moiseev, I. Foeldvari, A. Gabrielli, B. Krummel-Lorenz, S. Rednic, Y. Allanore, Ulf Müeller-Ladner (2019)
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort studyAnnals of the Rheumatic Diseases, 78
A. Flett, M. Hayward, M. Ashworth, M. Hansen, A. Taylor, P. Elliott, C. McGregor, J. Moon (2010)
Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in HumansCirculation, 122
S. Plastiras, N. Kelekis, G. Tzelepis (2006)
Magnetic resonance imaging for the detection of myocardial fibrosis in scleroderma.The New England journal of medicine, 354 20
N. Galiè, M. Humbert, J. Vachiéry, S. Gibbs, I. Lang, A. Torbicki, G. Simonneau, A. Peacock, A. Noordegraaf, M. Beghetti, A. Ghofrani, M. Sánchez, G. Hansmann, W. Klepetko, P. Lancellotti, M. Matucci, T. McDonagh, L. Pierard, P. Trindade, M. Zompatori, M. Hoeper (2016)
2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.Revista espanola de cardiologia, 69 2
C. Campochiaro, G. Luca, M. Santis (2019)
Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosisAnnals of the Rheumatic Diseases, 80
M. Pieroni, M. Santis, G. Zizzo, S. Bosello, C. Smaldone, M. Campioni, G. Luca, A. Laria, A. Meduri, F. Bellocci, L. Bonomo, F. Crea, G. Ferraccioli (2014)
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression.Seminars in arthritis and rheumatism, 43 4
A. Barison, L. Gargani, D. Marchi, G. Aquaro, S. Guiducci, E. Picano, M. Cerinic, A. Pingitore (2015)
Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance.European heart journal cardiovascular Imaging, 16 1
M. Penmetcha, Rosenbush Sw, Harris Ca (1996)
Cardiac valvular disease in scleroderma and systemic lupus erythematosus/scleroderma overlap associated with antiphospholipid antibodies.The Journal of rheumatology, 23 12
S Bosello (2015)
10.1056/NEJMoa1415921N Engl J Med, 373
N Galiè (2016)
10.1093/eurheartj/ehv317Eur Heart J, 37
B. Pussadhamma, Thapanee Tipparot, Naruemol Chaosuwannakit, A. Mahakkanukrauh, S. Suwannaroj, R. Nanagara, C. Foocharoen (2020)
Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot StudyInternational Journal of Rheumatology, 2020
A. Palmisano, G. Benedetti, R. Faletti, P. Rancoita, M. Gatti, G. Peretto, S. Sala, E. Boccia, M. Francone, N. Galea, C. Basso, A. Maschio, F. Cobelli, A. Esposito (2020)
Early T1 Myocardial MRI Mapping: Value in Detecting Myocardial Hyperemia in Acute Myocarditis.Radiology
C. Bruni, L. Ross (2021)
Cardiac involvement in systemic sclerosis: Getting to the heart of the matter.Best practice & research. Clinical rheumatology
D. Mukerjee, D. George, B. Coleiro, C. Knight, C. Denton, J. Davar, C. Black, J. Coghlan (2003)
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approachAnnals of the Rheumatic Diseases, 62
C. Campochiaro, N. Farina, A. Tomelleri, R. Ferrara, C. Lazzari, G. Luca, A. Bulotta, D. Signorelli, A. Palmisano, D. Vignale, G. Peretto, S. Sala, A. Esposito, M. Garassino, V. Gregorc, L. Dagna (2021)
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series.European journal of internal medicine
C. Jellis, Jennifer Martin, J. Narula, T. Marwick (2010)
Assessment of nonischemic myocardial fibrosis.Journal of the American College of Cardiology, 56 2
Mikael Kanski, H. Arheden, D. Wuttge, G. Bozovic, R. Hesselstrand, M. Ugander (2013)
Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals – a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changesJournal of Cardiovascular Magnetic Resonance, 15
CP Denton (2017)
10.1016/S0140-6736(17)30933-9Lancet, 390
N. Rowell (1968)
Systemic sclerosis.British Medical Journal, 1
M. Fontana, S. White, S. Banypersad, D. Sado, V. Maestrini, A. Flett, S. Piechnik, S. Neubauer, N. Roberts, J. Moon (2012)
Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMRJournal of Cardiovascular Magnetic Resonance, 14
A. Swift, S. Rajaram, R. Condliffe, D. Capener, J. Hurdman, C. Elliot, J. Wild, D. Kiely (2012)
Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registryJournal of Cardiovascular Magnetic Resonance, 14
S. Mavrogeni, M. Buch, G. Markousis-Mavrogenis, B. Dumitru, N. Pugliese, L. Gargani (2020)
The perpetual sword of Damocles: Cardiac involvement in systemic sclerosis and the role of non-invasive imaging modalities in medical decision making.European journal of rheumatology
A. Moreo, G. Ambrosio, B. Chiara, M. Pu, T. Tran, F. Mauri, S. Raman (2009)
Influence of Myocardial Fibrosis on Left Ventricular Diastolic Function: Noninvasive Assessment by Cardiac Magnetic Resonance and EchoCirculation: Cardiovascular Imaging, 2
G. Luca, S. Bosello, A. Leone, F. Gabrielli, G. Pelargonio, F. Inzani, F. Crea, G. Ferraccioli (2017)
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburstScandinavian Journal of Rheumatology, 46
S Mavrogeni (2020)
10.1093/rheumatology/kez494.PMID:31764972;PMCID:PMC7382593Rheumatology (Oxford), 59
S. Mavrogeni, E. Gialafos, G. Karabela, E. Stavropoulos, E. Sfendouraki, G. Kolovou (2013)
"The silence of lambs": Cardiac lesions in asymptomatic immune-mediated diseases detected by cardiovascular magnetic resonance.International journal of cardiology, 168 3
S. Bull, S. White, S. Piechnik, A. Flett, V. Ferreira, M. Loudon, J. Francis, T. Karamitsos, B. Prendergast, M. Robson, S. Neubauer, J. Moon, S. Myerson (2013)
Human non-contrast T1 values and correlation with histology in diffuse fibrosisHeart, 99
S. Bohnen, U. Radunski, G. Lund, F. Ojeda, Y. Looft, M. Senel, L. Radziwolek, M. Avanesov, E. Tahir, C. Stehning, B. Schnackenburg, G. Adam, S. Blankenberg, K. Muellerleile (2017)
Tissue characterization by T1 and T2 mapping cardiovascular magnetic resonance imaging to monitor myocardial inflammation in healing myocarditisEuropean Heart Journal - Cardiovascular Imaging, 18
G. Luca, C. Campochiaro, S. Franchini, S. Sartorelli, C. Candela, G. Peretto, S. Sala, L. Dagna (2018)
Unexpected acute lymphocytic virus-negative myocarditis in a patient with limited cutaneous systemic sclerosis: a case reportScandinavian Journal of Rheumatology, 48
G. Ferrari, S. Pratali, A. Pucci, U. Bortolotti (2015)
Aortic valve replacement in systemic sclerosisJournal of Cardiovascular Medicine, 16
S. White, D. Sado, M. Fontana, S. Banypersad, V. Maestrini, A. Flett, S. Piechnik, M. Robson, D. Hausenloy, A. Sheikh, P. Hawkins, J. Moon (2013)
T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.JACC. Cardiovascular imaging, 6 9
U. Radunski, G. Lund, D. Säring, S. Bohnen, C. Stehning, B. Schnackenburg, M. Avanesov, E. Tahir, G. Adam, S. Blankenberg, K. Muellerleile (2016)
T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditisClinical Research in Cardiology, 106
S. Mavrogeni, L. Koutsogeorgopoulou, G. Karabela, E. Stavropoulos, G. Katsifis, John Raftakis, S. Plastiras, M. Noutsias, G. Markousis-Mavrogenis, G. Kolovou (2017)
Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteriaBMC Cardiovascular Disorders, 17
A. Noordegraaf, R. Naeije (2008)
Right ventricular function in scleroderma-related pulmonary hypertension.Rheumatology, 47 Suppl 5
G. Luca, S. Bosello, F. Gabrielli, G. Berardi, F. Parisi, M. Rucco, G. Canestrari, F. Loperfido, L. Galiuto, F. Crea, G. Ferraccioli (2016)
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse OutcomePLoS ONE, 11
L. Bissell, Marina Anderson, M. Burgess, K. Chakravarty, G. Coghlan, R. Dumitru, L. Graham, V. Ong, J. Pauling, S. Plein, D. Schlosshan, P. Woolfson, M. Buch (2017)
Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosisRheumatology, 56
BH Bulkley (1976)
10.1161/01.cir.53.3.483A cause of cardiac dysfunction Circulation, 53
C. Campochiaro, G. Luca, A. Tomelleri, S. Sartorelli, G. Peretto, S. Sala, A. Palmisano, A. Esposito, G. Cavalli, L. Dagna (2019)
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use.JCR: Journal of Clinical Rheumatology
Fuyao Yang, Jie Wang, Weihao Li, Yuanwei Xu, Ke Wan, Rui Zeng, Yucheng Chen (2020)
The prognostic value of late gadolinium enhancement in myocarditis and clinically suspected myocarditis: systematic review and meta-analysisEuropean Radiology, 30
Y. Allanore, C. Meune, M. Vonk, P. Airò, E. Hachulla, P. Caramaschi, G. Riemekasten, F. Cozzi, L. Beretta, C. Derk, A. Komócsi, D. Farge, A. Balbir, V. Riccieri, O. Distler, A. Chialà, N. Papa, K. Simic, M. Ghio, B. Stamenkovic, S. Rednic, N. Høst, R. Pellerito, E. Zegers, A. Kahan, U. Walker, M. Matucci-Cerinic (2009)
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosisAnnals of the Rheumatic Diseases, 69
V. Smith, C. Scirè, R. Talarico, P. Airó, T. Alexander, Y. Allanore, C. Bruni, V. Codullo, Virgil Dalm, J. Vries-Bouwstra, A. Rossa, O. Distler, I. Galetti, D. Launay, G. Lepri, A. Mathian, L. Mouthon, B. Ruaro, A. Sulli, A. Tincani, E. Vandecasteele, A. Vanhaecke, M. Vanthuyne, F. Hoogen, R. Vollenhoven, A. Voskuyl, E. Zanatta, S. Bombardieri, G. Burmester, J. Fonseca, C. Frank, E. Hachulla, F. Houssiau, U. Mueller-Ladner, Matthias Schneider, J. Laar, A. Vieira, M. Cutolo, M. Mosca, M. Matucci-Cerinic (2018)
Systemic sclerosis: state of the art on clinical practice guidelinesRMD Open, 4
A. Tyndall, B. Bannert, M. Vonk, P. Airó, F. Cozzi, P. Carreira, D. Bancel, Y. Allanore, U. Müller-Ladner, O. Distler, F. Iannone, R. Pellerito, M. Pileckytė, I. Miniati, L. Ananieva, A. Gurman, N. Damjanov, Adelheid Mueller, G. Valentini, G. Riemekasten, M. Tikly, L. Hummers, M. Henriques, P. Caramaschi, A. Scheja, B. Rozman, E. Ton, G. Kumánovics, B. Coleiro, E. Feierl, G. Szűcs, C. Mühlen, V. Riccieri, S. Novak, C. Chizzolini, A. Kotulska, C. Denton, P. Coelho, I. Kötter, I. Simsek, P. Lefebvre, E. Hachulla, J. Seibold, S. Rednic, J. Štork, J. Morović-Vergles, U. Walker (2010)
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnnals of the Rheumatic Diseases, 69
D. Messroghli, J. Moon, V. Ferreira, L. Grosse-Wortmann, T. He, P. Kellman, J. Mascherbauer, R. Nezafat, M. Salerno, E. Schelbert, A. Taylor, Richard Thompson, M. Ugander, Ruud Heeswijk, M. Friedrich (2017)
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)Journal of Cardiovascular Magnetic Resonance, 19
V. Bordonaro, D. Bivort, T. Dresselaers, E. Langhe, J. Bogaert, R. Symons (2020)
Myocardial T1 mapping and extracellular volume quantification as novel biomarkers in risk stratification of patients with systemic sclerosis.Clinical radiology
R. Khouzam, I. D’Cruz, M. Arroyo, Daniel Minderman (2008)
Systemic scleroderma with moderate to severe mitral regurgitation: unusual three-dimensional echocardiographic features.The Canadian journal of cardiology, 24 2
N. Schicchi, G. Valeri, G. Moroncini, G. Agliata, L. Salvolini, A. Gabrielli, A. Giovagnoni (2014)
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonanceLa radiologia medica, 119
G. Tzelepis, N. Kelekis, S. Plastiras, Panayiotis Mitseas, N. Economopoulos, C. Kampolis, E. Gialafos, I. Moyssakis, H. Moutsopoulos (2007)
Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study.Arthritis and rheumatism, 56 11
S. Mavrogeni, L. Gargani, A. Pepe, L. Monti, G. Markousis-Mavrogenis, M. Santis, D. Marchi, L. Koutsogeorgopoulou, G. Karabela, E. Stavropoulos, G. Katsifis, K. Bratis, S. Bellando-Randone, S. Guiducci, C. Bruni, A. Moggi-Pignone, T. Dimitroulas, G. Kolovou, V. Bournia, P. Sfikakis, M. Matucci-Cerinic (2019)
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS)Rheumatology (Oxford, England), 59
B. Carter (2013)
2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular PathologyYearbook of Pathology and Laboratory Medicine, 2013
N. Ntusi, S. Piechnik, J. Francis, V. Ferreira, A. Rai, P. Matthews, M. Robson, J. Moon, P. Wordsworth, S. Neubauer, T. Karamitsos (2014)
Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis – a clinical study using myocardial T1-mapping and extracellular volume quantificationJournal of Cardiovascular Magnetic Resonance, 16
S. Mavrogeni, J. Schwitter, L. Gargani, A. Pepe, L. Monti, Y. Allanore, M. Matucci-Cerinic (2017)
Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls".Seminars in arthritis and rheumatism, 47 1
R. Benza, R. Biederman, S. Murali, H. Gupta (2008)
Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension.Journal of the American College of Cardiology, 52 21
PMCID: PMC7647675)
K. Mueller, I. Mueller, David Eppler, C. Zuern, P. Seizer, U. Kramer, I. Koetter, M. Roecken, R. Kandolf, M. Gawaz, T. Geisler, J. Henes, K. Klingel (2015)
Clinical and Histopathological Features of Patients with Systemic Sclerosis Undergoing Endomyocardial BiopsyPLoS ONE, 10
O. Leone, J. Veinot, A. Angelini, U. Baandrup, C. Basso, G. Berry, P. Bruneval, M. Burke, J. Butany, F. Calabrese, G. d’Amati, W. Edwards, J. Fallon, M. Fishbein, P. Gallagher, M. Halushka, Bruce McManus, A. Pucci, E. Rodriguez, J. Saffitz, M. Sheppard, C. Steenbergen, J. Stone, Carmela Tan, G. Thiene, A. Wal, G. Winters (2012)
2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology.Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, 21 4
M. Al-Mashaleh, H. Bak, J. Moore, N. Manolios, H. Englert (2006)
Resolution of sclerodermatous myocarditis after autologous stem cell transplantationAnnals of the Rheumatic Diseases, 65
G. Luca, C. Campochiaro, C. Dinarello, L. Dagna, G. Cavalli (2018)
Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition.Annals of internal medicine, 169 11
M. Sano, H. Satoh, Kenichiro Suwa, M. Nobuhara, Takeji Saitoh, M. Saotome, T. Urushida, H. Katoh, Kumiko Shimoyama, D. Suzuki, N. Ogawa, Y. Takehara, H. Sakahara, H. Hayashi (2014)
Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosisHeart and Vessels, 30
B. Bulkley, R. Ridolfi, W. Salyer, G. Hutchins (1976)
Myocardial Lesions of Progressive Systemic Sclerosis: A Cause of Cardiac DysfunctionCirculation, 53
T. Rodríguez-Reyna, M. Morelos-Guzmán, P. Hernández‐Reyes, Karla Montero-Duarte, Cynthia Martínez-Reyes, Carlos Reyes-Utrera, J. Madrid, J. Morales-Blanhir, C. Nuñez-Alvarez, Javier Cabiedes-Contreras (2015)
Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography.Rheumatology, 54 4
G. Bezante, D. Rollando, M. Sessarego, N. Panico, M. Setti, G. Filaci, G. Molinari, M. Balbi, M. Cutolo, A. Barsotti, F. Indiveri, M. Ghio (2007)
Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis.The Journal of rheumatology, 34 12
S. Mavrogeni, K. Bratis, G. Karabela, G. Spiliotis, K. Wijk, D. Hautemann, J. Reiber, L. Koutsogeorgopoulou, G. Markousis-Mavrogenis, G. Kolovou, E. Stavropoulos (2015)
Cardiovascular Magnetic Resonance Imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis.Inflammation & allergy drug targets, 14 1
G. Valentini, D. Vitale, A. Giunta, S. Maione, G. Gerundo, M. Arnese, E. Tirri, N. Pelaggi, A. Giacummo, G. Tirri, M. Condorelli (1996)
Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve.Annals of the Rheumatic Diseases, 55
J. Gottdiener, H. Moutsopoulos, J. Decker (1979)
Echocardiographic identification of cardiac abnormality in scleroderma and related disorders.The American journal of medicine, 66 3
C. Campochiaro, G. Luca, S. Sartorelli, A. Tomelleri, A. Esposito, C. Candela, G. Cavalli, L. Dagna (2018)
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
S. Bosello, G. Luca, G. Berardi, G. Canestrari, C. Waure, F. Gabrielli, C. Mario, F. Forni, E. Gremese, G. Ferraccioli (2019)
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.European journal of internal medicine, 60
DR Messroghli (2017)
10.1186/s12968-017-0389-8.Erratum.In:JCardiovascMagnReson.2018Feb7;20(1):9.PMID:28992817;PMCID:PMC5633041J Cardiovasc Magn Reson, 19
G. Luca, C. Campochiaro, M. Santis, S. Sartorelli, G. Peretto, S. Sala, G. Canestrari, E. Lorenzis, C. Basso, S. Rizzo, G. Thiene, A. Palmisano, A. Esposito, C. Selmi, E. Gremese, P. Bella, L. Dagna, S. Bosello (2020)
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis.Rheumatology
V. Ferreira, S. Piechnik (2020)
CMR Parametric Mapping as a Tool for Myocardial Tissue CharacterizationKorean Circulation Journal, 50
N. Galiè, M. Humbert, J. Vachiéry, S. Gibbs, I. Lang, A. Torbicki, G. Simonneau, A. Peacock, A. Noordegraaf, M. Beghetti, A. Ghofrani, M. Sánchez, G. Hansmann, W. Klepetko, P. Lancellotti, M. Matucci, T. McDonagh, L. Pierard, P. Trindade, M. Zompatori, M. Hoeper (2015)
[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].Kardiologia polska, 73 12
J. Henes, I. Koetter, M. Horger, M. Schmalzing, K. Mueller, C. Eick, A. Bauer, W. Vogel, L. Kanz (2014)
Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations.Rheumatology, 53 5
B. Freed, M. Gomberg-Maitland, S. Chandra, V. Mor-Avi, S. Rich, S. Archer, E. Bruce, J. Jr., R. Lang, Amit Patel (2012)
Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertensionJournal of Cardiovascular Magnetic Resonance, 14
J. Moon, J. Coghlan, D. Pennell (2001)
Systemic sclerosis involving the heartHeart, 86
VM Ferreira (2020)
10.4070/kcj.2020.0157.PMID:32725975;PMCID:PMC7390720Korean Circ J, 50
J. Coghlan, C. Denton, E. Grünig, D. Bonderman, O. Distler, D. Khanna, U. Müller-Ladner, Janet Pope, M. Vonk, M. Doelberg, H. Chadha‐Boreham, H. Heinzl, Daniel Rosenberg, Vallerie McLaughlin, James Seibold (2013)
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyAnnals of the Rheumatic Diseases, 73
H. Champion (2008)
The heart in scleroderma.Rheumatic diseases clinics of North America, 34 1
A. Esposito, M. Francone, R. Faletti, Maurizio Centonze, Filippo Cademartiri, I. Carbone, R. Rosa, E. Cesare, L. Grutta, G. Ligabue, L. Lovato, E. Maffei, R. Marano, M. Midiri, G. Pontone, L. Natale, F. Cobelli (2015)
Lights and shadows of cardiac magnetic resonance imaging in acute myocarditisInsights into Imaging, 7
S. Mavrogeni, J. Schwitter, A. Rossum, R. Nijveldt, A. Aletras, G. Kolovou, G. Pohost, J. Lima (2018)
Cardiac magnetic resonance imaging in myocardial inflammation in autoimmune rheumatic diseases: An appraisal of the diagnostic strengths and limitations of the Lake Louise criteria.International journal of cardiology, 252
M. Friedrich, U. Sechtem, J. Schulz-Menger, G. Holmvang, P. Alakija, L. Cooper, James White, H. Abdel-Aty, M. Gutberlet, S. Prasad, A. Aletras, J. Laissy, I. Paterson, N. Filipchuk, Andreas Kumar, M. Pauschinger, P. Liu (2009)
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper.Journal of the American College of Cardiology, 53 17
S. Rednic, L. Damian, R. Talarico, C. Scirè, A. Tobias, N. Costedoat-Chalumeau, D. Launay, A. Mathian, Lisa Matthews, C. Ponte, P. Toniati, S. Bombardieri, C. Frank, Matthias Schneider, V. Smith, M. Cutolo, M. Mosca, L. Arnaud (2018)
Relapsing polychondritis: state of the art on clinical practice guidelinesRMD Open, 4
G. Luca, G. Cavalli, C. Campochiaro, C. Bruni, A. Tomelleri, L. Dagna, M. Matucci-Cerinic (2021)
Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac InvolvementFrontiers in Immunology, 12
N. Galea, E. Rosato, A. Gigante, C. Borrazzo, A. Fiorelli, G. Barchetti, A. Trombetta, M. DiGiulio, M. Francone, C. Catalano, I. Carbone (2020)
Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: A cardiovascular magnetic resonance study with cold pressor testPLoS ONE, 15
Systemic sclerosis (SSc) is a severe connective tissue disease characterized by diffuse vascular damage and aberrant activation of immune system, resulting in inflammation and fibrosis of skin and internal organs, including the heart. Cardiac involvement is frequent in SSc, even though often unrecognized due to the occult nature at early stages and to the lack of a defined diagnostic algorithm. Once clinically evident, heart involvement is associated with a poor prognosis, representing the leading cause of death in about one third of SSc patients. Thus, its early recognition and monitoring are of crucial importance to allow a prompt therapeutic intervention and to improve patients’ outcomes. Cardiac Magnetic Resonance (CMR) is a non-invasive, non-radiating imaging technique of great importance for the assessment of cardiovascular system, and represents the modality of choice for the morpho-functional and structural characterization of the heart. In SSc, CMR allows a precise definition of biventricular and biatrial size and function, and a detailed tissue characterization. CMR has been therefore extensively proposed in SSc as a non-invasive diagnostic tool to characterize heart involvement, particularly myocardial involvement. In this review, we summarize the most recent evidences to support the use of CMR in SSc as an important tool to recognize and characterize scleroderma heart disease. Furthermore, the unmet needs and the future perspectives of a CMR-based approach for the early detection of SSc heart involvement are discussed.
Clinical Reviews in Allergy & Immunology – Springer Journals
Published: Jun 1, 2023
Keywords: Systemic sclerosis; Cardiac magnetic resonance; Heart involvement; Myocarditis; Fibrosis
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.